Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $14.45M in the quarter ending March 31, 2026, with 65.67% growth. This brings the company's revenue in the last twelve months to $50.27M, down -7.30% year-over-year. In the year 2025, Aquestive Therapeutics had annual revenue of $44.55M, down -22.61%.

• Revenue (ttm): $50.27M
• Revenue Growth: -7.30%
• P/S Ratio: 10.32
• Revenue / Employee: $341,980
• Employees: 147
• Market Cap: 511.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	44.55M	-13.02M	-22.61%
Dec 31, 2024	57.56M	6.98M	13.80%
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%
Dec 31, 2018	67.43M	512.00K	0.77%
Dec 31, 2017	66.92M	15.13M	29.22%
Dec 31, 2016	51.79M	49.07M	1,807.37%
Dec 31, 2006	2.72M	592.00K	27.89%
Dec 31, 2005	2.12M	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error